Dr. Fang Tian, Lead Scientist, is the head of the Cell Biology Collection at ATCC. Dr. Tian has extensive experience in cell biology and molecular biology, cell banking and bio-processing. She is responsible for overseeing over 3,400 human, animal cell lines and hybridomas in the Cell Biology General Collection. Her R&D team has been accessing scientific high-value cell lines from various species, as well as developing advanced cell models focusing on disease, molecular signatures, cell signaling pathways, and genetic alternation.
Her previous research field covers cancer genomics, programmed cell death, neovascularization, stem cell and progenitor cell differentiation, as well as anti-cancer drug screening. Dr. Tian was a research fellow in Massachusetts General Hospital, Harvard Medical School. She conducted postdoctoral research at the Hillman Cancer Institute of the University of Pittsburgh Medical Center. Dr. Tian obtained her Ph.D degree from Chinese Academy of Sciences, Shanghai Institute of Materia Medica.